Cite this asSoliman GZA (2019) Serum/Urine Zn Level of Egyptian Type II Diabetic Patients and Its relation with Glycemic Control (HbA1c). J Biol Med 3(1): 044-047. DOI: 10.17352/jbm.000014
Introduction: Diabetes Mellitus is a metabolic disorder disease characterized by hyperglycemia due to impaired insulin secretion or action. Percent of Type 2 diabetic patients are getting to increase annually allover the world especially in developing countries. It is estimated to increase to 300 million in 2025. In Egypt around 8.1 million are estimated according to IDF 2015. Zinc is a trace element that acts as co-factor for synthesis, storage, stability and secretion of insulin by pancreas. There is a controversy studies regarding Levels of trace elements as Zinc in diabetic patients.
Aim: To assess the level of zinc in Egyptian type 2 diabetic patients and its relation to glycemic control.
Material and methods: One hundred and twenty type 2 diabetic patients, with duration of diabetes > 2 years, age 30-45 year; and 60 age and sex matched; healthy normal controls receiving oral antidiabetic drugs were included in this study. Serum Zn, Fasting blood sugar (FBS) and HbA1c levels were estimated. Diabetic patients were divided into 2 groups, 60 diabetics /group: controlled diabetics (HbA1c < 7); and uncontrolled diabetics (HbA1c > 7).
Results: Serum Zn levels of uncontrolled diabetics were significantly lower (56.18 ± 0.66 µg/dl) than controlled diabetic (76.61 ± 2.44) and normal controls (84.30 ± 0.98 µg/dl, p < 0.001). An inverse significant correlation with found between serum concentration of zinc and FBS; and HbA1c in uncontrolled diabetics.
Conclusion: Altered levels of trace elements as Zn are found to be important predisposing factors for diabetic patients.
Diabetes mellitus is the most prevalent disease worldwide that affects millions of individuals every year across the world. It represents a major public health problem. Type 2 diabetes mellitus has a rising attitude globally. The worldwide spread of diabetes among general population is estimated to increase to 300 million in 2025 [1,2]. In Egypt around 8.1 million are estimated according to IDF 2015.
Zinc (Zn) is a trace element that acts as co-factor for synthesis, storage, stability and secretion of insulin by pancreas and it accounts for the conformation integrity of insulin in its hexameric crystalline form [3,4]. Zinc may be involved in the regulation of insulin receptor-initiated signal transudation mechanism and insulin receptor synthesis. Also Zn acts as a cofactor for the function of intracellular enzymes that may be involved in protein, lipid and glucose metabolism or participate as an integral component of several antioxidant enzymes. Zinc has an important role in the glucose utilization by muscle and fat cells [5,6].
Pancreatic β cells contain very high concentrations of zinc compared with various other cells. In particular, Insulin secretory granules have the highest zinc content within β cells . Metallothioneins (MTs), zinc importers (ZIP, SLC39A), and zinc exporters (ZnT, SLC30A) are proteins that regulate cellular zinc homeostasis [4,8]. ZnT8 plays a key role in the accumulation of zinc within insulin secretory granules . Furthermore, zinc is essential for the appropriate synthesis of insulin, as well as its storage and structural stability .
Insulin comprises a hexamer of six insulin and two zinc molecules , in β-cells of the pancreas. Insulin crystallization occurs under specific conditions in insulin secretory granules, in which both insulin and zinc exist in high concentrations and acidic pH is maintained . Insulin is released into the portal venous system at the time of β-cells de-granulation where it dissociates rapidly into monomers.
Anderson et al.,  reported that 30% patients with DM found to be zinc deficient. There are different data regarding Zn level in diabetic patients where some authors (large number) stated that Zn is deficient in diabetics [5,11], others found no change [12,13], others found an increase in Zn concentration [14,15].
An informed consent was collected from all the participants. Study was approved by the ethical committee of GOTHI (Egypt).
One hundred and twenty type 2 diabetic patients; and 60 age and sex matched healthy controls were included in this study. Under strict aseptic conditions blood sample was collected from all the participants. Serum Zn, Fasting blood sugar (FBS) and glycated hemoglobin (HbA1c) levels were estimated. Glucose was determined using Randox kit . HbA1c was determined using Stanbio kits procedure No. 0350 (Stanbio laboratory, Boerne, Texas; DN: RBR.0350CE.00) according to Trivelli et al., . Zn in serum/urine was determined using QCA Kits (Spain) according to Makino et al., , and Homster and Zak . Diabetic patients were divided into 2 groups, 60 diabetics/ group: controlled diabetics (HbA1c < 7); and uncontrolled diabetics (HbA1c > 7) according to Rohlfing et al., , and Gopinath et al., . Urine samples were collected for Zn determination.
Diabetic patients, with duration of diabetes > 2 years, age 30-45 year; oral anti-diabetic drugs (glibenclamide).
Patients who are taking zinc supplementation or drugs that interfere with zinc absorption, patients with chronic disease and pregnancy/ lactation, smokers, patients with history of acute infections and thyroid dysfunction were excluded from this study.
Data was expressed as Mean ± SEM. Statistical analysis was performed using SPSS version 11. Statistical tests as t-test, ANOVA/ Duncan post hoc and correlation coefficient were applied. P < 0.05 was considered statistically significant.
Results of FBS, HbA1c, Serum / Urine Zn are presented in figures 1-4. A significant increase in mean FBS of uncontrolled diabetic patients when compared with normal control / or control diabetic (252.88 ± 3.13 vs 94.01 ±1.18 &118.49 ± 2.44 mg/dl, P < 0.001) was found. A significant increase in mean hbA1c of uncontrolled diabetic patients when compared with normal control / or control diabetic (9.98 ± 0.20 vs 6.19 ± 0.31 &6.98 ± 0.22 g%, P < 0.001). Mean serum zinc was significantly lower in uncontrolled diabetic patients (56.18 ± 0.66 µg/dl) compared to healthy subjects (84.30 ± 0.98 mcg/dl, p < 0.001), or controlled diabetic (76.61 ± 2.44). Mean urinary zinc was significantly higher in uncontrolled diabetic patients (46.64 ± 1.84 µg/dl) compared to healthy subjects (32.92 ± 1.00 µg/dl, p < 0.001), or controlled diabetic (34.29 ± 0.86). Urine Zn level of uncontrolled diabetic is significantly higher than healthy control persons, diabetic.
Diabetes has been shown to be major causes of death all over the world. The prevalence of diabetes in developed countries represents a major public health problem. Insulin is stored inside secretory vesicles or granules, where two Zn2+ ions coordinate six insulin monomers to form the hexameric-structure on which maturated insulin crystals are formed .
Our study revealed that diabetic subjects had significantly low mean zinc levels than control subjects (p < 0.001) either uncontrolled diabetic or normal persons. Our results agree with Al-Maroof et al., , Kazi et al., , Sahria and Goswami , Saha-roy et al., , where they found a significant decrease in serum Zn level in uncontrolled diabetic patients when compared with normal persons or versus diabetic patients.
The low zinc level in the diabetic patients may be due to the decreased gastrointestinal absorption and increased urinary excretion , or due to some effects of alteration of other minerals, especially copper , or due to the interfering of hyperglycemia with the active transport of zinc back into the renal tubular cells leading to more urinary excretion of zinc as stated by Tripathy et al., . Also Kinlaw et al., , explained that zinc absorption has been defect or reduced, by uncontrolled blood sugar (hyperglycemia) and it would lead to an elevation of HbA1c.
Our results disagree with Zargar et al., , and Unjiati et al., , where they found no significant change when compared with normal persons. Also our results disagree with Osman et al., , and Mumza et al., , where they found significant change (increase) when compared with normal persons.
Zn deficiency in diabetic patients diminish its role as antioxidant against free radical oxidation (characteristic of diabetes mellitus, hyperglycemia) since Zn is a component / cofactor of the important antioxidant enzyme superoxide dismutase (Cu-Zn SOD) that regulates the expression of metallothioneins and glutamate-cysteine ligase, thus affecting glutathione levels [30,5,6). Also it might affect the release of vitamin A from the storage site in the liver and metabolism , and it also affect synthesis, storage and structural stability of insulin . Zn deficiency may cause impaired glucose tolerance, insulin degradation, insulin resistance and reduced pancreatic insulin content [32,33].
In our study the FBS was negatively inverse correlated with serum concentration of zinc (r=-0.672, p <0.001) in uncontrolled diabetics which disagree with Mumza et al., , where they found no significant relation of zinc concentration with FBS.
In the present study, it was observed that the mean HbA1c concentration in uncontrolled type 2 diabetic patients had an inverse relation with serum zinc concentration (r=-0.615, p <0.001) which agrees with Al-Maroof et al., , i.e. with the increase in HbA1c levels there is decrease in zinc levels. Lower Zn level might lead to higher blood glucose as a result of low insulin synthesis or action and consequently, higher HbA1c. It also agrees with Viktorinova et al., , and Somayeh et al., . In contrast, Dorre et al., , showed no significant correlation between serum Zn level and HbA1c. The disagreement may be due to dependence of HbA1c on treatment of diabetes not on Zn level (Table 1, Figure 5).
Egyptian diabetic patients had significantly low level of Zn. There was a negative relationship among serum zinc and FBS; and HbA1c.Further studies are required.
Subscribe to our articles alerts and stay tuned.